Partial reversal of heparin anticoagulation by intravenous protamine in abciximab-treated patients undergoing percutaneous intervention.

Kereiakes, D J

Partial reversal of heparin anticoagulation by intravenous protamine in abciximab-treated patients undergoing percutaneous intervention. [electronic resource] - The American journal of cardiology Sep 1997 - 633-4 p. digital

Publication Type: Journal Article

0002-9149

10.1016/s0002-9149(97)00437-2 doi


Abciximab
Adult
Aged
Aged, 80 and over
Angioplasty, Balloon, Coronary
Antibodies, Monoclonal--therapeutic use
Female
Humans
Immunoglobulin Fab Fragments--therapeutic use
Male
Middle Aged
Platelet Aggregation Inhibitors--therapeutic use
Protamines--therapeutic use